[1] crystal structure of (4-hydroxypiperidin-1-yl)(4-methylphenyl)methanone

[2] crystal structure of bis[2-(1h-benzimidazol-2-yl)aniline]silver(i) nitrate

[3] crystal structure of bis(2,2′-bipyridine-κ2n,n′)bis(thiocyanato-κn)manganese(ii) 2,2′-bipyridine monosolvate

[4] crystal structure of tetraaquabis(3,5-diamino-4h-1,2,4-triazol-1-ium)cobalt(ii) bis[bis(pyridine-2,6-dicarboxylato)cobaltate(ii)] dihydrate

[5] crystal structure of 4-methoxy-n-[(pyrrolidin-1-yl)carbothioyl]benzamide

[6] crystal structures of 3,5-bis[(e)-3-hydroxybenzylidene]-1-methylpiperidin-4-one and 3,5-bis[(e)-2-chlorobenzylidene]-1-methylpiperidin-4-one

[7] crystal structure of 7,7-dimethyl-6-methylidenetricyclo[6.2.1.01,5]undecane-2-carboxylic acid

[8] crystal structure of ethyl 2-[2-((1e)-{(1e)-2-[2-(2-ethoxy-2-oxoethoxy)benzylidene]hydrazin-1-ylidene}methyl)phenoxy]acetate

[9] crystal structure of creatininium 5-(2,4-dinitrophenyl)-1,3-dimethylbarbiturate monohydrate: a potential anticonvulsant agent

[10] crystal structure of 1-[(1s,2r)-2-hydroxy-1-methyl-2-phenylethyl]pyrrolidinium 2-amino-5-chlorobenzoate

[11] crystal structure of 2-phenylethanaminium 3-carboxyprop-2-enoate

[12] crystal structure of cyproconazole

[13] crystal structure of 2-(4-fluoro-3-methylphenyl)-5-{[(naphthalen-1-yl)oxy]methyl}-1,3,4-oxadiazole

[14] the tripeptide n-cbz-βgly-gly-gly-obz

[15] crystal structure of 2-azido-1h-imidazole-4,5-dicarbonitrile

[16] crystal structures of {μ2-n,n′-bis[(pyridin-3-yl)methyl]ethanediamide}tetrakis(dimethylcarbamodithioato)dizinc(ii) dimethylformamide disolvate and {μ2-n,n′-bis[(pyridin-3-yl)methyl]ethanediamide}tetrakis(di-n-propylcarbamodithioato)dizinc(ii)

[17] crystal structure of 4-formyl-2-nitrophenyl 4-chloro-2-nitrobenzoate

[18] a copper(ii) paddle-wheel structure of tranexamic acid: dichloro-tetrakis[μ-4-(ammoniomethyl)cyclohexane-1-carboxylato-o,o′]dicopper(ii) dichloride hexahydrate

[19] crystal structures of bis[4-(dimethylamino)pyridinium] tetrakis(thiocyanato-κn)manganate(ii) and tris[4-(dimethylamino)pyridinium] pentakis(thiocyanato-κn)manganate(ii)

[20] crystal structure of (1s,3r,8r,9r)-2,2-dichloro-3,7,7-trimethyl-10-methylenetricyclo[6.4.0.01,3]dodecan-9-ol

[21] crystal structure of tris(hydroxylammonium) orthophosphate

[22] crystal structure of heptaguanidinium nonahydrogen bis[α-hexamolybdoplatinate(iv)] heptahydrate

[23] crystal structure of 2-(1h-imidazol-3-ium-4-yl)ethanaminium dichloride, a re-determination

[24] crystal structure of diethyl (e)-2-[(benzofuran-2-yl)methylidene]succinate

[25] crystal structure of 15-(2-chlorophenyl)-6b-hydroxy-17-methyl-6b,7,16,17-tetrahydro-7,14a-methanonaphtho[1′,8′:1,2,3]pyrrolo[3′,2′:8,8a]azuleno[5,6-b]quinolin-14(15h)-one

[26] crystal and molecular structures of two silver(i) amidinates, including an unexpected co-crystal with a lithium amidinate

[27] crystal structure of ethyl 2,4-dichloroquinoline-3-carboxylate

[28] crystal structure of 14-methyl-11-(3-methylphenyl)-12-oxa-8,14-diazatetracyclo[8.3.3.01,10.02,7]hexadeca-2(7),3,5-triene-9,13-dione

[29] crystal structure of 7,8-benzocoumarin-4-acetic acid

[30] structure of the mercury(ii) mixed-halide (br/cl) complex of 2,2′-(5-tert-butyl-1,3-phenylene)bis(1-pentyl-1h-benzo[d]imidazole)

[31] crystal structure and hirshfeld surface analysis of 3,3′,3′′-[(1,3,5-triazine-2,4,6-triyl)tris(oxy)]tris(5,5-dimethylcyclohex-2-en-1-one)

[32] crystal structure of methyl 4-(4-hydroxyphenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate monohydrate

[33] crystal structure of catena-poly[[[aqualithium(i)]-μ-pyrimidine-2-carboxylato-κ4n1,o2:n3,o2′] hemihydrate]

[34] crystal structure of 2-(2,3-dimethylanilino)-n′-[(1e)-2-hydroxybenzylidene]benzohydrazide

[35] crystal structure of (s)-5,7-diphenyl-4,7-dihydrotetrazolo[1,5-a]pyrimidine

[36] crystal structure of poly[(2,2′-bipyridine-κ2n,n′)tetra-μ2-cyanido-κ4c:n;κ4n:c-manganese(ii)disilver(i)]

[37] crystal structure of 2,4,6-tris(cyclohexyloxy)-1,3,5-triazine

[38] crystal structure of tris[μ2-bis(diphenylphosphanyl)methane-κ2p:p′]di-μ3-bromido-trisilver(i) bromide–n,n′-phenylthiourea (1/1)

[39] crystal structure of (z)-3-(4-methoxybenzylidene)-2,3-dihydrobenzo[b][1,4]thiazepin-4(5h)-one